Literature DB >> 6086696

The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: the effect of naloxone on LH, follicle-stimulating hormone, prolactin, and beta-endorphin secretion.

B Baranowska, G Rozbicka, W Jeske, M H Abdel-Fattah.   

Abstract

The aim of this study was to evaluate the role of endogenous opiates in the mechanism of decreased LH secretion in women with anorexia nervosa. For this purpose the effect of opiate receptor blockade with naloxone on LH, FSH, PRL, and beta-endorphins secretion was studied in 24 women with anorexia nervosa and 7 normal women. Serum LH, FSH, PRL, beta-endorphin-like substance, ACTH, and cortisol concentrations were measured before and after opiate receptor blockade after a single iv dose of 0.2 mg/kg naloxone or saline. Mean serum LH and FSH concentrations increased significantly after naloxone in the normal women. Eleven patients had a significant increase in serum LH concentrations in response to naloxone and 13 did not respond to naloxone with an increase in LH concentration. In the first group the basal LH values were higher than those in the second group. In the majority of patients in the first group amenorrhea preceded the wt loss, whereas in most patients in the second group amenorrhea appeared during the phase of wt loss. Naloxone did not alter pulsatile LH secretion in 6 women. No effect of naloxone on serum FSH and PRL concentrations was found. A significant increase in beta-endorphin-like substance levels after naloxone administration occurred in patients with anorexia nervosa. However, serum ACTH and cortisol concentrations were not altered in response to naloxone. In conclusion, the increase in LH release after opiate receptor blockade by naloxone suggests that endogenous opiates may play a role in the mechanism of inhibited LH secretion at least, in the majority of those women with anorexia nervosa in whom amenorrhea preceded wt loss. The results also point to a different mechanism of ACTH and beta-endorphin secretion in patients with anorexia nervosa.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6086696     DOI: 10.1210/jcem-59-3-412

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Effects of opioid receptor blockade on luteinizing hormone (LH) pulses and interpulse LH concentrations in normal women during the early phase of the menstrual cycle.

Authors:  W S Evans; J Y Weltman; M L Johnson; A Weltman; J D Veldhuis; A D Rogol
Journal:  J Endocrinol Invest       Date:  1992 Jul-Aug       Impact factor: 4.256

Review 2.  Menstrual function and its relationship to stress, exercise, and body weight.

Authors:  P R Gindoff
Journal:  Bull N Y Acad Med       Date:  1989-09

Review 3.  Current perspectives on drug therapies for anorexia nervosa and bulimia nervosa.

Authors:  S H Kennedy; D S Goldbloom
Journal:  Drugs       Date:  1991-03       Impact factor: 9.546

4.  Naltrexone potentiates 4-aminopyridine seizures in the rat.

Authors:  A Mihály; K Bencsik; T Solymosi
Journal:  J Neural Transm Gen Sect       Date:  1990

5.  Evidence for a positive correlation between serum cortisol levels and IL-1beta production by peripheral mononuclear cells in anorexia nervosa.

Authors:  P Limone; A Biglino; F Bottino; B Forno; P Calvelli; S Fassino; C Berardi; P Ajmone-Catt; A Bertagna; R P Tarocco; G G Rovera; G M Molinatti
Journal:  J Endocrinol Invest       Date:  2000 Jul-Aug       Impact factor: 4.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.